Biotechnology Stocks Are Future AI Winners. Two Top Values at 52-Week High!
Reading Time: 3 minutes
We expect biotechnology to be a winner in AI. New therapies will be discovered that shorten R&D phases and thereby initiate innovation-driven growth. In our model portfolios, we already hold two core positions with BB Biotech (investment in 40 companies) and Medpace (contract research organization). Two biotechnology stocks now stand out with a bullish price behavior. Celldex: A Hidden Gem from Guggenheim with Doubling Potential Guggenheim Securities has named Celldex Therapeutics – a biopharmaceutical company focused on developing targeted...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
